New Zealand markets open in 3 hours 28 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
267.84-0.33 (-0.12%)
As of 12:32PM EST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 20.87B
Enterprise value 20.44B
Trailing P/E 34.17
Forward P/E 34.48
PEG ratio (5-yr expected) 4.87
Price/sales (ttm)7.40
Price/book (mrq)8.45
Enterprise value/revenue 7.03
Enterprise value/EBITDA 23.61

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-33.07%
S&P500 52-week change 3-9.08%
52-week high 3424.00
52-week low 3206.19
50-day moving average 3245.12
200-day moving average 3278.00

Share statistics

Avg vol (3-month) 3649.69k
Avg vol (10-day) 3559.4k
Shares outstanding 574.03M
Implied shares outstanding 6N/A
Float 873.6M
% held by insiders 10.63%
% held by institutions 196.60%
Shares short (12 Jan 2023) 41.27M
Short ratio (12 Jan 2023) 42.26
Short % of float (12 Jan 2023) 42.24%
Short % of shares outstanding (12 Jan 2023) 41.72%
Shares short (prior month 14 Dec 2022) 41.16M

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 40.28%
Trailing annual dividend rate 30.72
Trailing annual dividend yield 30.27%
5-year average dividend yield 40.34
Payout ratio 48.73%
Dividend date 331 Jan 2023
Ex-dividend date 423 Jan 2023
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 21.68%
Operating margin (ttm)25.50%

Management effectiveness

Return on assets (ttm)14.36%
Return on equity (ttm)26.99%

Income statement

Revenue (ttm)2.91B
Revenue per share (ttm)38.94
Quarterly revenue growth (yoy)-2.80%
Gross profit (ttm)1.18B
EBITDA 865.8M
Net income avi to common (ttm)630.6M
Diluted EPS (ttm)8.25
Quarterly earnings growth (yoy)-31.30%

Balance sheet

Total cash (mrq)729M
Total cash per share (mrq)9.85
Total debt (mrq)299.9M
Total debt/equity (mrq)12.14
Current ratio (mrq)3.80
Book value per share (mrq)33.39

Cash flow statement

Operating cash flow (ttm)654M
Levered free cash flow (ttm)183.49M